• Fibrobiologics walks the unconventional financing path

  • May 15 2024
  • Duración: 18 m
  • Podcast

Fibrobiologics walks the unconventional financing path Por arte de portada

Fibrobiologics walks the unconventional financing path

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • A non-traditional route for financing has been the path to success for Fibrobiologics Inc. In the newest BioWorld Insider podcast, CEO Pete O’Heeron offers insight into the company’s unusual path to a Nasdaq listing in January. SPACs, reverse mergers and traditional IPOs weren’t attractive enough for Fibrobiologics’ management or board, so they decided to go public through a direct listing with no banks as underwriters. It took about seven months to get the company ready for its listing, an around-the-clock effort that O’Heeron said was worth the effort. “We couldn’t be more happy with the outcome,” he said.
    Más Menos
activate_primeday_promo_in_buybox_DT
Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Fibrobiologics walks the unconventional financing path

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles